For the year ending 2025-12-31, RXRX has $1,474,130K in assets. $343,265K in debts. $743,294K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 743,294 | 594,350 | 391,565 | 549,912 |
| Restricted cash | 4,594 | 3,045 | 3,231 | 1,280 |
| Accounts receivable | - | - | - | 0 |
| Other receivables | 24,649 | 49,166 | 3,094 | 2,753 |
| Investments | - | - | - | 0 |
| Prepaid data assets | 11,742 | - | - | - |
| Other current assets | 28,566 | 67,708 | 40,247 | 15,869 |
| Total current assets | 812,845 | 714,269 | 438,137 | 569,814 |
| Restricted cash, non-current | 6,033 | 5,629 | 6,629 | 7,920 |
| Property and equipment, net | 103,931 | 141,063 | 86,510 | 88,192 |
| Operating lease right-of-use assets | 45,339 | 65,877 | 33,663 | 33,255 |
| Financing lease right-of-use assets | 20,210 | 26,273 | - | - |
| Net carrying amount | - | - | 35,457 | 402 |
| Indefinite-lived intangible assets | - | - | 986 | 904 |
| Intangible assets, net | 309,903 | 335,855 | 36,443 | 1,306 |
| Goodwill | 162,158 | 148,873 | 52,056 | 801 |
| Deferred tax assets | 957 | 1,934 | - | - |
| Other assets, non-current | 12,754 | 8,825 | 261 | 0 |
| Total assets | 1,474,130 | 1,448,598 | 653,699 | 701,288 |
| Accounts payable | 18,118 | 21,613 | 3,953 | 4,586 |
| Accrued expenses and other liabilities | 70,230 | 81,872 | 46,635 | 32,904 |
| Unearned revenue | 37,605 | 61,767 | 36,426 | 56,726 |
| Notes payable | - | - | 41 | 97 |
| Operating lease liabilities | 12,663 | 13,795 | 6,116 | 5,952 |
| Lease incentive obligation | - | - | - | 0 |
| Notes payable and financing lease liabilities | 9,091 | 8,425 | - | - |
| Total current liabilities | 147,707 | 187,472 | 93,171 | 100,265 |
| Deferred rent | - | - | - | 0 |
| Unearned revenue, non-current | 114,012 | 118,765 | 51,238 | 70,261 |
| Notes payable, non-current | - | - | 1,101 | 536 |
| Operating lease liabilities, non-current | 46,647 | 67,250 | 43,414 | 44,420 |
| Notes payable and financing lease liabilities, non-current | 9,564 | 19,022 | - | - |
| Deferred tax liabilities | 23,255 | 16,575 | 1,339 | - |
| Lease incentive obligation, non-current | - | - | - | 0 |
| Other liabilities, non-current | 2,080 | 4,732 | - | - |
| Total liabilities | 343,265 | 413,816 | 190,263 | 215,482 |
| Common stock, 0.00001 par value 2,000,000,000 shares (class a 1,989,032,117 and class b 10,967,883) authorized as of december31, 2025 and december31, 2024 528,182,693 shares (class a 521,831,046, class b 5,547,334 and exchangeable 804,313) and 396,802,394 (class a 389,547,223 and class b 6,958,575 and exchangeable 296,596) issued and outstanding as of december31, 2025 and december31, 2024, respectively | 5 | 4 | 2 | 2 |
| Additional paid-in capital | 3,170,145 | 2,473,698 | 1,431,056 | 1,125,360 |
| Accumulated deficit | -2,076,002 | -1,431,283 | -967,622 | -639,556 |
| Accumulated other comprehensive income (loss) | 36,717 | -7,637 | - | 0 |
| Total stockholders equity | 1,130,865 | 1,034,782 | 463,436 | 485,806 |
| Total liabilities and stockholders equity | 1,474,130 | 1,448,598 | 653,699 | 701,288 |
RECURSION PHARMACEUTICALS, INC. (RXRX)
RECURSION PHARMACEUTICALS, INC. (RXRX)